U.S. appeals court maintains six-month notice for generic-like biological drugs
Friday, July 8, 2016 - 09:21
in Mathematics & Economics
Ruling could delay introduction of lower-priced biosimilar
Ruling could delay introduction of lower-priced biosimilar